These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 25783511)

  • 1. The impact of DaTscan in the diagnosis of Parkinson disease.
    Gayed I; Joseph U; Fanous M; Wan D; Schiess M; Ondo W; Won KS
    Clin Nucl Med; 2015 May; 40(5):390-3. PubMed ID: 25783511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Impact of 123I-Ioflupane SPECT (DaTscan) in a Movement Disorder Center.
    Graebner AK; Tarsy D; Shih LC; Vanderhorst V; Kulkarni O; Kaplan S; Simon DK
    Neurodegener Dis; 2017; 17(1):38-43. PubMed ID: 27614874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPECT study with I-123-Ioflupane (DaTSCAN) in patients with essential tremor. Is there any correlation with Parkinson's disease?
    Gerasimou G; Costa DC; Papanastasiou E; Bostanjiopoulou S; Arnaoutoglou M; Moralidis E; Aggelopoulou T; Gotzamani-Psarrakou A
    Ann Nucl Med; 2012 May; 26(4):337-44. PubMed ID: 22382608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcranial Sonography and DaTSCAN in Early Stage Parkinson's Disease and Essential Tremor.
    Jesus-Ribeiro J; Freire A; Sargento-Freitas J; Sousa M; Silva F; Moreira F; Cunha MJ; Walter U; Januário C
    Eur Neurol; 2016; 76(5-6):252-255. PubMed ID: 27750247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of DaTSCAN (123I-Ioflupane) SPECT in diagnosis of patients with clinically uncertain parkinsonism: 2-year follow-up of an open-label study.
    Tolosa E; Borght TV; Moreno E;
    Mov Disord; 2007 Dec; 22(16):2346-51. PubMed ID: 17914722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of an Objective Striatal Analysis Program for Determining Laterality in Uptake of ¹²³I-Ioflupane SPECT Images: Comparison to Clinical Symptoms and to Visual Reads.
    Kuo PH; Lei HH; Avery R; Krupinski EA; Bauer A; Sherman S; McMillan N; Seibyl J; Zubal GI
    J Nucl Med Technol; 2014 Jun; 42(2):105-8. PubMed ID: 24627411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [
    Ahmed A; Huang J; Chen K; Zubeldia JM; Booij J; Vijayakumar V
    J Neurol Sci; 2018 Dec; 395():159-163. PubMed ID: 30336391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of (123)I-ioflupane SPECT and Myocardial MIBG Scintigraphy to Determine the Candidate of Deep Brain Stimulation for Parkinson's Disease.
    Asahi T; Kashiwazaki D; Yoneyama T; Noguchi K; Kuroda S
    Neurol Med Chir (Tokyo); 2016; 56(3):125-31. PubMed ID: 26794041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is DaTSCAN really needed for accurate Parkinson's disease diagnosis?
    de la Fuente-Fernández R
    Expert Rev Neurother; 2012 Dec; 12(12):1375-7. PubMed ID: 23237344
    [No Abstract]   [Full Text] [Related]  

  • 10. 123I-FP-CIT brain SPECT (DaTSCAN) imaging in the diagnosis of patients with movement disorders--first results.
    Jauković L; Ilić TV; Dopudja M; Ajdinović B
    Vojnosanit Pregl; 2012 Feb; 69(2):157-62. PubMed ID: 22500370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of DaTscan SPECT imaging on clinical management, diagnosis, confidence of diagnosis, quality of life, health resource use and safety in patients with clinically uncertain parkinsonian syndromes: a prospective 1-year follow-up of an open-label controlled study.
    Kupsch AR; Bajaj N; Weiland F; Tartaglione A; Klutmann S; Buitendyk M; Sherwin P; Tate A; Grachev ID
    J Neurol Neurosurg Psychiatry; 2012 Jun; 83(6):620-8. PubMed ID: 22492213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of CT based attenuation correction on quantitative assessment of DaTSCAN ((123)I-Ioflupane) imaging in diagnosis of extrapyramidal diseases.
    Bieńkiewicz M; Górska-Chrzastek M; Siennicki J; Gajos A; Bogucki A; Mochecka-Thoelke A; Płachcińska A; Kuśmierek J
    Nucl Med Rev Cent East Eur; 2008; 11(2):53-8. PubMed ID: 19585455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of DaTSCAN and clinical diagnosis in Parkinson disease.
    de la Fuente-Fernández R
    Neurology; 2012 Mar; 78(10):696-701. PubMed ID: 22323748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interobserver variability, and visual and quantitative parameters of (123)I-FP-CIT SPECT (DaTSCAN) studies.
    Papathanasiou N; Rondogianni P; Chroni P; Themistocleous M; Boviatsis E; Pedeli X; Sakas D; Datseris I
    Ann Nucl Med; 2012 Apr; 26(3):234-40. PubMed ID: 22237674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine transporter imaging (123)I-FP-CIT (DaTSCAN) SPET in differential diagnosis of dopa-responsive dystonia and young-onset Parkinson's disease.
    Brajkovic LD; Svetel MV; Kostic VS; Sobic-Saranovic DP; Pavlovic SV; Artiko VM; Obradovic VB
    Hell J Nucl Med; 2012; 15(2):134-8. PubMed ID: 22833860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individual-reader diagnostic performance and between-reader agreement in assessment of subjects with Parkinsonian syndrome or dementia using 123I-ioflupane injection (DaTscan) imaging.
    Seibyl JP; Kupsch A; Booij J; Grosset DG; Costa DC; Hauser RA; Darcourt J; Bajaj N; Walker Z; Marek K; McKeith I; O'Brien JT; Tatsch K; Tolosa E; Dierckx RA; Grachev ID
    J Nucl Med; 2014 Aug; 55(8):1288-96. PubMed ID: 24925885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: part 1. Baseline and 3-month observations.
    Benamer HT; Oertel WH; Patterson J; Hadley DM; Pogarell O; Höffken H; Gerstner A; Grosset DG
    Mov Disord; 2003 Sep; 18(9):977-84. PubMed ID: 14502664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computed-tomography-guided anatomic standardization for quantitative assessment of dopamine transporter SPECT.
    Yokoyama K; Imabayashi E; Sumida K; Sone D; Kimura Y; Sato N; Mukai Y; Murata M; Matsuda H
    Eur J Nucl Med Mol Imaging; 2017 Mar; 44(3):366-372. PubMed ID: 27544223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating ioflupane I
    Reams N; Anderson J; Perlman R; Li W; Walters S; Tideman S; Wang C; Simon K; Frigerio R; Maraganore DM
    Brain Inj; 2018; 32(1):105-112. PubMed ID: 29131690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between visual assessment of dopaminergic degeneration pattern and semi-quantitative ratio calculations in patients with Parkinson's disease and Atypical Parkinsonian syndromes using DaTSCAN® SPECT.
    Davidsson A; Georgiopoulos C; Dizdar N; Granerus G; Zachrisson H
    Ann Nucl Med; 2014 Nov; 28(9):851-9. PubMed ID: 24997753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.